ClinConnect ClinConnect Logo
Search / Trial NCT05502718

Exercise Program for Patients With Cervical Dystonia Who Are Treated With Botulinum Toxin Type A

Launched by PROF. DR. ŞEHIM KUTLAY · Aug 14, 2022

Trial Information

Current as of July 05, 2025

Recruiting

Keywords

Botulinum Toxin Type A Exercise Quality Of Life

ClinConnect Summary

This clinical trial is studying the effects of a personalized exercise program for patients with cervical dystonia who are receiving botulinum toxin type A injections. Cervical dystonia is a condition that causes involuntary movements and abnormal postures of the neck, which can lead to pain and difficulties in daily activities. The trial aims to see if adding specific exercises—like stretching and strengthening—can improve patients' quality of life and reduce their symptoms compared to a control group that will only do basic breathing and coordination exercises.

To participate, individuals must be over 18 years old, have a confirmed diagnosis of cervical dystonia, and be receiving treatment at Ankara University. They should also be able to access exercise videos on a computer or mobile device. However, anyone with serious health issues that might prevent them from exercising, or with certain mental health conditions, cannot join the study. Participants can expect to engage in a tailored exercise program that may help manage their symptoms better alongside their regular treatment.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Be over 18 years old
  • Completion of Informed Signed Consent Form
  • Diagnosis of cervical dystonia by neurology
  • Botulinum toxin injection for cervical dystonia in Ankara University Faculty of Medicine Neurology Department Movement Disorders Outpatient Clinic
  • To have the necessary infrastructure to watch the prepared exercise videos on computers, phones, tablets.
  • Exclusion Criteria:
  • Cardiovascular, systemic or musculoskeletal problems that prevent participation in the exercise program
  • Presence of dementia/cognitive disorder or symptomatic psychiatric disease, which was previously diagnosed or detected during the anamnesis process, preventing participation in the program
  • Failure to approve the Informed Signed Consent Form

About Prof. Dr. şehim Kutlay

Prof. Dr. Şehim Kutlay is a distinguished clinical trial sponsor renowned for his extensive expertise in medical research and commitment to advancing healthcare. With a robust background in clinical methodologies and a focus on innovative treatment approaches, Dr. Kutlay leads multidisciplinary teams in the design and execution of trials that adhere to the highest ethical and regulatory standards. His work emphasizes patient-centered outcomes and aims to bridge the gap between scientific discovery and practical application, ultimately contributing to the development of effective therapeutic strategies in various medical fields.

Locations

Ankara, , Turkey

Ankara, Altındağ, Turkey

Patients applied

0 patients applied

Trial Officials

Sehim Sehim

Study Director

sehim.kutlay@gmail.com

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials